Land: USA
Språk: engelska
Källa: NLM (National Library of Medicine)
ERYTHROMYCIN (UNII: 63937KV33D) (ERYTHROMYCIN - UNII:63937KV33D)
Mylan Pharmaceuticals Inc.
TOPICAL
PRESCRIPTION DRUG
Erythromycin topical gel is indicated for the topical treatment of acne vulgaris. Erythromycin topical gel is contraindicated in those individuals who have shown hypersensitivity to any of its components.
Erythromycin Topical Gel USP, 2% contains 20 mg of erythromycin, USP per gram. The clear to slightly yellow gel is available as follows: NDC 0378-8212-93 carton containing one 30 g tube NDC 0378-8212-60 carton containing one 60 g tube
New Drug Application Authorized Generic
ERYTHROMYCIN- ERYTHROMYCIN GEL MYLAN PHARMACEUTICALS INC. ---------- DESCRIPTION Erythromycin topical gel USP, 2% contains erythromycin (3R*, 4S*, 5S*, 6R*, 7R*, 9R*, 11R*, 12R*, 13S*, 14R*)-4-[(2,6-Dideoxy-3-_C_-methyl-3-_O_-methyl-α-L-_ribo_-hexopyranosyl)oxy]-14-ethyl-7, 12, 13-trihydroxy-3, 5, 7, 9, 11, 13-hexamethyl-6-[[3, 4, 6,-trideoxy-3-(dimethylamino)-β-D-_xylo_- hexopyranosyl]oxy]oxacyclotetradecane-2,10-dione), for topical dermatological use. Erythromycin is a macrolide antibiotic produced from a strain of _Saccaropolysporaerythraea _(formerly _Streptomyces erythreus_). It is a base and readily forms salts with acids. Chemically, erythromycin is C H NO . It has the following structural formula: Erythromycin has a molecular weight of 733.94. It is a white or slightly yellow, odorless or practically odorless, bitter crystalline powder. Erythromycin is very soluble in very polar organic solvents such as alcohols, acetone, chloroform, acetonitrile and ethyl acetate. It is moderately soluble in less polar solvents such as ether, dichloroethylene and amyl acetate. It is slightly soluble in nonpolar solvents such as hexane. It is very poorly soluble in water. Each gram of erythromycin topical gel USP, 2% contains 20 mg of erythromycin, USP in a vehicle consisting of dehydrated alcohol and hydroxypropyl cellulose. CLINICAL PHARMACOLOGY The exact mechanism by which erythromycin reduces lesions of acne vulgaris is not fully known; however, the effect appears to be due in part to the antibacterial activity of the drug. MICROBIOLOGY Erythromycin acts by inhibition of protein synthesis in susceptible organisms by reversibly binding to 50S ribosomal subunits, thereby inhibiting translocation of aminoacyl transfer-RNA and inhibiting polypeptide synthesis. Antagonism has been demonstrated _in vitro _between erythromycin, lincomycin, chloramphenicol, and clindamycin. INDICATIONS AND USAGE Erythromycin topical gel is indicated for the topical treatment of acne vulgaris. 37 67 13 CONTRAINDICATIONS Erythromycin topical Läs hela dokumentet